Sign in
4

Changes in Ownership

Adaptive Biotechnologies Corp Filed Acc 0001209191-21-003914

Director sold 6,000 shares at an average $65.88 ($395,253)

  • Director acquired 6,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

GRIFFIN MICHELLE RENEE · Director

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2021-01-14 Exercise or conversion : show line 1 in the form +6,000 $7.80 $46,800 6,000 D
2021-01-14 Sale : show line 2 in the form −5,041 $65.77 $331,547 959 D
2021-01-14 Sale : show line 3 in the form −959 $66.43 $63,706 0 D
Open-market sales · 6,000 sh · avg $65.88 · $395,253

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2021-01-14 Exercise or conversion : show line 4 in the form Stock Option (Right to Buy) −6,000 95,000 D
Loading xslF345X03/doc4.xml…